- Antitrust analysis
- Competitive effects
- Consumer protection
- Healthcare economics
- Industrial organization
- Market definition
- Market power
- Mergers and acquisitions
- Public policy
- Health insurance
- Physician groups
Martin Gaynor, PhD
- Academic Affiliate
- For contact information, please see below
Martin Gaynor is the E.J. Barone Professor of Economics and Public Policy at Carnegie Mellon University’s H. John Heinz III College. Dr. Gaynor is a Research Associate at the National Bureau of Economic Research and an International Research Fellow at the University of Bristol’s Centre for Market and Public Organisation.
From 2013–2014, Dr. Gaynor served as Director of the Bureau of Economics at the Federal Trade Commission (FTC), where he supervised economic analysis and advised the agency on economic policy matters. In his FTC role, Dr. Gaynor oversaw a staff of nearly 80 economists, advising on a wide range of antitrust and consumer protection issues ranging from horizontal and vertical mergers to anticompetitive practices (e.g., reverse payment settlements) to practices unfair to consumers (e.g., mobile throttling and cramming). Notable cases overseen by Dr. Gaynor while at the FTC included FTC v. Sysco, FTC v. St. Luke’s Health System, In re Apple, Inc., Proposed Merger of Office Depot, Inc. and OfficeMax, Inc., In re AmeriGas and Blue Rhino, FTC v. T-Mobile USA, Inc., In re North Carolina Board of Dental Examiners, FTC v. Phoebe Putney Health System Inc., and FTC v. AbbVie Inc. Dr. Gaynor was also the first chairman of the Health Care Cost Institute (HCCI), a research institution founded in 2011 that uses comprehensive commercial health insurance claims data to study the functioning of healthcare markets.
Dr. Gaynor has received numerous awards for his research and has published in multiple leading economics journals. His academic research focuses on competitive interactions among payers and providers of healthcare services, with an emphasis on antitrust, competitive strategy, industrial organization, and public policy. Recently, Dr. Gaynor and colleagues released a joint study demonstrating that the prices hospitals negotiate with private health insurance companies vary considerably within and across geographic regions in the United States.
In 2016, Dr. Gaynor was elected to the National Academy of Medicine, considered one of the highest honors in the fields of health and medicine.
- October 21, 2016
- May 18, 2016
- Martin Gaynor, Professor at Carnegie Mellon University and former Director of the Bureau of Economics at the Federal Trade Commission, joins Bates White Economic ConsultingMay 11, 2016
- Healthcare Mergers: A Post-MortemCompetition Policy International, July 2017
- Workshop on the Economics of Antitrust and Competition LawWashington, DC, February 15, 2018
- Tenth Annual FTC Microeconomics ConferenceWashington, DC, November 2, 2017
- October 27, 2016